Rare cardiovascular diseases list
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that rare cardiovascular diseases can be diagnosed and managed using various tools and strategies, including CMR imaging, genetic research, personalized approaches, comprehensive databases, updated classifications, and patient-specific disease models like iPSCs.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Rare Cardiovascular Diseases: A Comprehensive Overview
Introduction to Rare Cardiovascular Diseases (RCDs)
Rare cardiovascular diseases (RCDs) are conditions that affect the heart and blood vessels but have a low prevalence in the general population. Despite their rarity, these diseases can have significant clinical impacts and often require specialized diagnostic and therapeutic approaches . The classification of RCDs is essential for improving diagnosis, treatment, and research collaboration .
Classification of Rare Cardiovascular Diseases
Systemic Circulation Disorders
Class I RCDs involve systemic circulation issues, including diseases that affect the arteries and veins outside the heart. Examples include Marfan syndrome and Turner syndrome, which can lead to aortopathies.
Pulmonary Circulation Disorders
Class II RCDs affect the pulmonary circulation, such as pulmonary arterial hypertension (PAH) and thromboembolic pulmonary hypertension. These conditions can lead to severe complications if not properly managed.
Cardiomyopathies
Class III includes various cardiomyopathies, such as hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC). These diseases often have genetic underpinnings and can lead to heart failure or sudden cardiac death .
Congenital Cardiovascular Diseases
Class IV encompasses congenital cardiovascular diseases, which are present at birth. Examples include congenital heart defects like partial anomalous pulmonary venous connection and univentricular hearts .
Cardiac Tumors and CVD in Malignancy
Class V includes rare cardiac tumors and cardiovascular diseases associated with malignancies. These conditions are often challenging to diagnose and treat due to their complexity and the need for multidisciplinary care.
Cardiac Arrhythmogenic Disorders
Class VI covers inherited arrhythmias and other arrhythmogenic disorders, such as long QT syndrome (LQT), short QT syndrome (SQT), and Brugada syndrome (BrS). These conditions are often caused by genetic mutations affecting ion channels .
Cardiovascular Diseases in Pregnancy
Class VII includes cardiovascular diseases that specifically affect pregnant women. These conditions require careful management to ensure the safety of both the mother and the fetus.
Unclassified Rare Cardiovascular Diseases
Class VIII is a catch-all category for rare cardiovascular diseases that do not fit into the other classes. This category highlights the need for ongoing research and classification efforts to better understand and manage these conditions.
Diagnostic and Therapeutic Approaches
Cardiovascular Magnetic Resonance Imaging (CMR)
CMR is a valuable tool for diagnosing and managing RCDs. It allows for comprehensive imaging, including angiography, function, perfusion, and tissue characterization in a single examination. Specific imaging patterns, such as late gadolinium enhancement (LGE) and T1 mapping, can help identify various RCDs.
Genetic Testing and Precision Medicine
Genetic testing plays a crucial role in diagnosing monogenic cardiovascular diseases and understanding the genetic basis of RCDs. Precision medicine approaches, including the use of induced pluripotent stem cells (iPSCs), offer opportunities for patient-specific therapies and better disease modeling .
Multidisciplinary Care
The management of RCDs often requires a multidisciplinary approach involving cardiologists, geneticists, nurses, social workers, and other healthcare professionals. This collaborative effort is essential for providing comprehensive care and improving patient outcomes .
Conclusion
Rare cardiovascular diseases, though uncommon, pose significant challenges in diagnosis and treatment. A thorough understanding of their classification, coupled with advanced diagnostic tools and multidisciplinary care, is essential for improving patient outcomes. Ongoing research and collaboration are crucial for advancing our knowledge and management of these complex conditions.
Sources and full results
Most relevant research papers on this topic
